Nature’s Sunshine Products, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Capital Transactions (Details 2)

Capital Transactions (Details 2) (USD $) In Thousands, except Per Share data, unless otherwise specified	0 Months Ended		9 Months Ended	3 Months Ended		9 Months Ended			9 Months Ended						9 Months Ended
	Sep. 19, 2013 Stock options	Aug. 29, 2013 Stock options	Sep. 30, 2014 Stock options	Sep. 30, 2014 Time-based stock options	Sep. 30, 2013 Time-based stock options	Sep. 30, 2014 Time-based stock options	Sep. 30, 2013 Time-based stock options	Dec. 31, 2013 Time-based stock options	Sep. 30, 2014 Time-based stock options Maximum	Sep. 30, 2014 Performance based stock options operating income margins	Sep. 30, 2014 Performance based stock options sales and operating income margins	Sep. 30, 2014 Performance based stock options sales and operating income margins Minimum	Sep. 30, 2014 Performance based stock options sales	Sep. 30, 2014 Performance based stock options sales Maximum	Sep. 30, 2014 2012 Stock Incentive Plan Time-based stock options
Number of shares
Options outstanding at the beginning of the period (in shares)			1,926
Granted (in shares)			258												258
Expired (in shares)			(18)
Exercised (in shares)			(44)
Options outstanding at the end of the period (in shares)			2,122
Weighted Average Exercise Price Per Share
Options outstanding at the beginning of the period (in dollars per share)			$ 12.54
Granted (in dollars per share)			$ 15.38												$ 15.38
Expired (in dollars per share)			$ 13.55
Exercised (in dollars per share)			$ 7.32
Options outstanding at the end of the period (in dollars per share)			$ 12.97
Share-based compensation, additional disclosures
Vesting period									48 months		2 years
Operating income margin, one (as a percent)										6.00%
Operating income margin, two (as a percent)										8.00%		8.00%
Operating income margin, three (as a percent)										10.00%
Period of time during which operating income margins must be achieved in order to vest in performance based stock options										12 months
Consecutive period of time used to assess operating income margins which determine vesting										15 months
Vesting period based on achieving annual net sales targets													1 year
Expiration period															10 years
Weighted-average assumptions used to calculate fair value of options granted
Weighted-average grant date fair value (in dollars per share)															$ 6.53
Expected life			6 years
Risk-free interest rate (as a percent)			1.50%
Expected volatility (as a percent)			56.70%
Dividend yield (as a percent)			2.60%
Share-based compensation, related information
Special one-time cash dividend paid per common share (in dollars per share)	$ 1.50	$ 1.50
Share-based compensation expense				$ 691	$ 620	$ 2,307	$ 2,423
Related tax benefit				273	245	911	957
Unrecognized share-based compensation expense				2,627		2,627		3,294
Weighted-average period over which the remaining compensation cost is expected to be recognized						1 year 9 months 18 days
Potential compensation expense														$ 800